Skip to content
Clinical Trials – home
The NetherlandsBack to the Netherlands

Clinical trials in Schiedam – page 3

31 clinical trials in Schiedam, The Netherlands. Every trial is listed in the EU Clinical Trials Register and updated daily.

The NetherlandsOur site in the NetherlandsKlinischOnderzoek.nl(opens in a new tab)
Schiedam at a glance
31
clinical trials
  • Not yet recruiting0
  • Paediatric trials0
  • Research sites0
Type of trial
Recruitment status
Quick filters

31 trials in Schiedam

Open in trial search
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · 65+ years
  • Substances:Epcoritamab
  • Sponsor:AbbVie Deutschland GmbH & Co. KG
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · 65+ years
  • Substances:Cyclophosphamide
  • Sponsor:AbbVie Deutschland GmbH & Co. KG
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · 65+ years
  • Substances:Obinutuzumab
  • Sponsor:Hemato-Oncologie voor Volwassenen Nederland (Hovon) Stichting
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · 65+ years
  • Substances:Durvalumab
  • Sponsor:AstraZeneca AB
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · 65+ years
  • Substances:Acetylsalicylic Acid
  • Sponsor:Leids Universitair Medisch Centrum (LUMC)
Registered drug
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · 65+ years
  • Substances:Dostarlimab
  • Sponsor:Glaxosmithkline Research & Development Limited
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · 65+ years
  • Substances:Radium Ra 223 Dichloride
  • Sponsor:Memorial Sloan Kettering Cancer Center

Other cities in the Netherlands

The busiest research cities in the country

All 103 cities in the Netherlands

Clinical research in Schiedam

What the registry says about research in the country

01 Oncology - Solid Tumors

Clinical research focusing on advanced solid tumors, particularly investigating new therapeutic approaches for prostate, breast, and renal cell cancers. Several studies explore combination therapies with novel agents.

  • Prostate Cancer Treatment Innovations
  • Breast Cancer Therapeutic Strategies
  • Renal Cell Carcinoma Studies

Notable investigations include treatment options for metastatic disease and hormone-receptor-positive cancers.

02 Hematological Malignancies

Research centered on blood cancers, including innovative treatments for lymphomas, leukemia, and multiple myeloma. Studies evaluate targeted therapies and immunological approaches.

  • Lymphoma Treatment Protocols
  • Multiple Myeloma Therapies
  • Leukemia Management Strategies

Emphasis on developing treatment-free intervals and maintenance therapies for better patient outcomes.

03 Innovative Treatment Approaches

Studies exploring targeted therapies and immunological treatments across various cancer types. Focus on personalized medicine and biomarker-driven treatment selection.

  • Immunotherapy Combinations
  • Precision Medicine Applications
  • Novel Drug Development

Integration of molecular profiling and targeted approaches to enhance treatment efficacy.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.